Literature DB >> 32527379

Epidemiological Measures in the Context of the COVID-19 Pandemic.

Emilio Gianicolo1, Nicola Riccetti, Maria Blettner, André Karch.   

Abstract

BACKGROUND: The various epidemiological indicators used to communicate the impact of COVID-19 have different strengths and limitations.
METHODS: We conducted a selective literature review to identify the indicators used and to derive appropriate definitions. We calculated crude and age-adjusted indicators for selected countries.
RESULTS: The proportion of deaths (case fatality proportion [CFP]; number of deaths/ total number of cases) is commonly used to estimate the severity of a disease. If the CFP is used for purposes of comparison, the existence of heterogeneity in the detection and registration of cases and deaths has to be taken into account. In the early phase of an epidemic, when case numbers rise rapidly, the CFP suffers from bias. For these reasons, variants have been proposed: the "confirmed CFP" (number of deaths/total number of confirmed cases), and the "delay-adjusted CFP," which considers the delay between infection with the disease and death from the disease. The indicator mortality (number of deaths/total population) has at first sight the advantage of being based on a defined denominator, the total population. During the outbreak of a disease, however, the cumulative deaths rise while the total population remains stable. The phase of the epidemic therefore has to be considered when using this indicator. In this context, R0 and R(t) are important indicators. R0 estimates the maximum rate of spread of a disease in a population, while R(t) describes the dynamics of the epidemic at a given time. Age-adjusted analysis of the CFP shows that the differences between countries decrease but do not dis - appear completely. If the test strategies depend on age or symptom severity, however, the bias cannot be entirely eliminated.
CONCLUSION: Various indicators of the impact of the COVID-19 epidemic at population level are used in daily communication. Considering the relevance of the pandemic and the importance of relevant communications, however, the strengths and the limitations of each parameter must be considered carefully.

Entities:  

Mesh:

Year:  2020        PMID: 32527379     DOI: 10.3238/arztebl.2020.0336

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  16 in total

Review 1.  "Herd immunity": a rough guide.

Authors:  Paul Fine; Ken Eames; David L Heymann
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

2.  Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-04-15       Impact factor: 53.440

3.  Screening: part 19 of a series on evaluation of scientific publications.

Authors:  Claudia Spix; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2012-05-25       Impact factor: 5.594

Review 4.  Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Authors:  Marc Lipsitch; Christl A Donnelly; Christophe Fraser; Isobel M Blake; Anne Cori; Ilaria Dorigatti; Neil M Ferguson; Tini Garske; Harriet L Mills; Steven Riley; Maria D Van Kerkhove; Miguel A Hernán
Journal:  PLoS Negl Trop Dis       Date:  2015-07-16

5.  Under-reporting and case fatality estimates for emerging epidemics.

Authors:  Katherine E Atkins; Natasha S Wenzel; Martial Ndeffo-Mbah; Frederick L Altice; Jeffrey P Townsend; Alison P Galvani
Journal:  BMJ       Date:  2015-03-16

6.  Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures.

Authors:  Jacco Wallinga; Peter Teunis
Journal:  Am J Epidemiol       Date:  2004-09-15       Impact factor: 4.897

7.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.

Authors:  Natalie M Linton; Tetsuro Kobayashi; Yichi Yang; Katsuma Hayashi; Andrei R Akhmetzhanov; Sung-Mok Jung; Baoyin Yuan; Ryo Kinoshita; Hiroshi Nishiura
Journal:  J Clin Med       Date:  2020-02-17       Impact factor: 4.241

8.  Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.

Authors:  Chad R Wells; Pratha Sah; Seyed M Moghadas; Abhishek Pandey; Affan Shoukat; Yaning Wang; Zheng Wang; Lauren A Meyers; Burton H Singer; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-13       Impact factor: 11.205

9.  Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.

Authors:  Zhanwei Du; Xiaoke Xu; Ye Wu; Lin Wang; Benjamin J Cowling; Lauren Ancel Meyers
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

10.  Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).

Authors:  Hiroshi Nishiura; Tetsuro Kobayashi; Takeshi Miyama; Ayako Suzuki; Sung-Mok Jung; Katsuma Hayashi; Ryo Kinoshita; Yichi Yang; Baoyin Yuan; Andrei R Akhmetzhanov; Natalie M Linton
Journal:  Int J Infect Dis       Date:  2020-03-14       Impact factor: 3.623

View more
  15 in total

1.  Standardized Mortality Ratios.

Authors:  Thomas C Erren; Peter Morfeld
Journal:  Dtsch Arztebl Int       Date:  2020-10-30       Impact factor: 5.594

2.  In Reply.

Authors:  Emilio Gianicolo; Nicola Riccetti; Maria Blettner; André Karch
Journal:  Dtsch Arztebl Int       Date:  2020-10-30       Impact factor: 5.594

3.  Modern Burden of Disease Studies as a Basis for Decision-Making Processes in Public Health.

Authors:  André Karch
Journal:  Dtsch Arztebl Int       Date:  2021-03-05       Impact factor: 5.594

4. 

Authors:  Manfred Wildner
Journal:  Gesundheitswesen       Date:  2020-06-30

5.  [Management of diagnostic procedures and treatment of sleep related breathing disorders in the context of the coronavirus pandemic].

Authors:  N Büchner; H Woehrle; D Dellweg; A Wiater; P Young; H Hein; W Randerath
Journal:  Somnologie (Berl)       Date:  2020-06-22

6.  [Management of Diagnostic Procedures and Treatment of Sleep Related Breathing Disorders in the Context of the Coronavirus Pandemic - German Respiratory Society (DGP), German Sleep Society (DGSM)].

Authors:  N Büchner; H Woehrle; D Dellweg; A Wiater; P Young; H Hein; W Randerath
Journal:  Pneumologie       Date:  2020-06-10

7.  Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.

Authors:  Emilio A L Gianicolo; Antonello Russo; Britta Büchler; Katherine Taylor; Andreas Stang; Maria Blettner
Journal:  Eur J Epidemiol       Date:  2021-01-25       Impact factor: 8.082

8.  [SARS-CoV-2, influenza and norovirus infection : A direct epidemiologic comparison].

Authors:  M V Karg; B Alber; C Kuhn; K Bohlinger; M Englbrecht; H Dormann
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-02-09       Impact factor: 1.552

9.  Health Sufficiency Indicators for Pandemic Monitoring.

Authors:  Javier M Moguerza; Salvador Perelló Oliver; Isaac Martín de Diego; Víctor Aceña; Carmen Lancho; Marina Cuesta; César González Fernández
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

10.  The Epidemiological and Spatiotemporal Characteristics of the 2019 Novel Coronavirus Disease (COVID-19) in Libya.

Authors:  Mohamed A Daw; Abdallah H El-Bouzedi; Mohamed O Ahmed
Journal:  Front Public Health       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.